Vanderbilt University’s Satish Raj, M.D., MSCI, was very busy — and very visible — at the Dysautonomia International Conference in Washington, D.C., earlier this month.

A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer.

A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found.

Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.

Credo and Five Pillar Leader Award winners were announced Tuesday during the Summer 2014 Clinical Enterprise Leadership Assembly at Langford Auditorium.